NCT00924846

Brief Summary

Background/Objectives: Acute hypoxemic respiratory failure (AHRF) is a frequent cause of pediatric ICU admission. Early treatment with inhaled nitric oxide (iNO) plus conventional mechanical ventilation (CMV) improves oxygenation, responsiveness being significantly influenced by alveolar recruitment level. High-frequency oscillatory ventilation (HFV) is conceptually very attractive as constant mean airway pressure optimizes lung recruitment; this could maximize iNO effects. Aims: To analyze the effects of HFV on oxygenation indexes in AHRF children under CMV and iNO. Methods: Children with AHRF (oxygenation index ≥10) aged between one month and 14 years under CMV with PEEP≥10cmH2O and 5ppm iNO for 1h were randomly assigned to CMV (CMVG, n=12) or HFV (HFVG, n=12) in a crossover design. Children with chronic cardiac or pulmonary diseases were excluded. Patients were kept under one of the two ventilation modes for 8h, crossing to the other for 8h, and then back again to complete 24h observation. Blood gas analysis, oxygenation indexes, and hemodynamic variables were recorded at enrollment (Tind), 1h after iNO start and then every 4h (T4h etc). The Mann-Whitney U test compared group ages and PRISM scores, and the Fisher test genders. Moments and groups were compared by repeated measure analysis for independent groups. Significance was considered at p\<0.05.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
24

participants targeted

Target at below P25 for phase_3

Timeline
Completed

Started Apr 2005

Typical duration for phase_3

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2005

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2008

Completed
1.2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2009

Completed
17 days until next milestone

First Submitted

Initial submission to the registry

June 18, 2009

Completed
1 day until next milestone

First Posted

Study publicly available on registry

June 19, 2009

Completed
Last Updated

June 22, 2009

Status Verified

June 1, 2009

Enrollment Period

3 years

First QC Date

June 18, 2009

Last Update Submit

June 19, 2009

Conditions

Keywords

high frequency oscillatory ventilationrespiratory failurechildreninhaled nitric oxide

Outcome Measures

Primary Outcomes (1)

  • Oxygenation indexes

    2 years

Study Arms (2)

HFOV plus iNO

ACTIVE COMPARATOR

HFOV plus iNO: high frequency oscillatory ventilation plus inhaled nitric oxide

Procedure: High frequency oscillatory ventilation

CMV plus iNO

ACTIVE COMPARATOR

CMV (conventional mechanical ventilation) iNO (inhaled nitric oxide)

Procedure: High frequency oscillatory ventilation

Interventions

Mechanical ventilation as high frequency oscillatory ventilation for 8h periods

Also known as: HFOV
CMV plus iNOHFOV plus iNO

Eligibility Criteria

Age1 Month - 14 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Children with AHRF (oxygenation index ≥ 10) aged between one month and 14 years under CMV with PEEP ≥ 10 cmH2O and 5 ppm iNO for 1 hour.

You may not qualify if:

  • Children with chronic cardiac or pulmonary diseases.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

UNESP-Botucatu Medical School

Botucatu, São Paulo, 18.618-970, Brazil

Location

MeSH Terms

Conditions

Respiratory Insufficiency

Condition Hierarchy (Ancestors)

Respiration DisordersRespiratory Tract Diseases

Study Officials

  • Jose R Fioretto, MD, PhD

    UNESP-Botucatu Medical School

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER

Study Record Dates

First Submitted

June 18, 2009

First Posted

June 19, 2009

Study Start

April 1, 2005

Primary Completion

April 1, 2008

Study Completion

June 1, 2009

Last Updated

June 22, 2009

Record last verified: 2009-06

Locations